Yes Harlan. Those studies are looking very good. The fact they are stating that each study is either being submitted for publish or confirms previous study results is basically confirming they will all be positive.
The most important one is the Chinese children's study which looks at cognitive performance. I haven't yet met a Chinese parent who doesn't value their child's education. That study on its own will underpin A2M's growth and premium prices for years to come in China. They are now sitting at 3.5% of the Chinese IF market with their aim to reach 10%. As we all know, the IF is the only game in town when it comes to A2M's NPAT growth.
Results, page-101
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B | |||
| Open | High | Low | Value | Volume |
| $4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10795 | $4.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.83 | 5662 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |